baber/WOPTO huggingface dataset:
Patent AU-2013301629-B2 (AU)
Title: Pipe member made from iron for a buried pipeline, comprising an outer coating
Inventor: ALEXANDRE PASCAL
IPC: F16L58/08
Filed: 2013-08-01
Granted: 2017-09-14
Abstract: A pipe member (1) made from iron, in particular cast iron, for a buried pipeline, comprising an outer coating (9) comprising: - a first layer (11) comprising at least a porous zinc/aluminium alloy layer containing 5 to 60% aluminium in terms of mass; - a second layer (13) of adhesive positioned on the first layer (11); and - a third layer (15) positioned on the second layer (13) and comprising a synthetic organic material. A method for producing such a pipe member.
Patent AU-2013311288-B2 (AU)
Title: Devices and methods for culture of cells
Inventor: KASUTO HAREL
IPC: C12M1/00
Filed: 2013-08-31
Granted: 2015-04-16
Abstract: Devices and methods for culture of cells are provided. The devices can comprise a three- dimensional body having multiple two-dimensional surfaces extending inwardly from a periphery of the three-dimensional body towards an interior of the three-dimensional body, wherein the multiple two-dimensional surfaces are configured to support monolayer growth of eukaryotic cells over at least a majority of or all of the surface area of the multiple two- dimensional surfaces.
Patent AU-2013317761-B2 (AU)
Title: Coded picture buffer removal times signaled in picture and sub-picture timing supplemental enhancement information messages
Inventor: WANG YE-KUI
IPC: H04N19/00
Filed: 2013-09-23
Granted: 2017-12-07
Abstract: A video coding device, such as a video encoder or a video decoder, may be configured to code a sub-picture timing supplemental enhancement information (SEI) message associated with a first decoding unit (DU) of an access unit (AU). The video coding device may further code a duration between coded picture buffer (CPB) removal time of a second DU of the AU in decoding order and CPB removal time of the first DU in the sub-picture SEI message. The coding device may also derive a CPB removal time of the first DU based at least in part on the sub-picture timing SEI message.
Patent AU-2013336455-B2 (AU)
Title: Electrical transport wire made of an aluminum alloy, having high electrical conductivity
Inventor: COMORET EMILIEN
IPC: H01B1/02
Filed: 2013-10-16
Granted: 2017-06-08
Abstract: The invention relates to an electrical transport wire made of an aluminum alloy including aluminum, zirconium and unavoidable impurities, characterized in that said alloy includes at least 80 parts by weight of zirconium in the form of precipitates (Al3Zr) per 100 parts by weight of zirconium in said alloy.
Patent AU-2013336818-B2 (AU)
Title: Wind power plant and wind power plant tower
Inventor: POLLMANN FRANK
IPC: F03D1/00
Filed: 2013-10-22
Granted: 2016-12-22
Abstract: The invention relates to a wind power plant with a tower (102) which has a plurality of tower segments. Some of the tower statements are constructed from a plurality of tower segment parts (10a). The tower segment parts (10a) are fastened to one another via screw connections. The wind power plant additionally has at least one guide rope (4) extending at least partially along the length of the tower. The wind power plant also has a work platform (1), which can be fastened to the guide rope (4) for guidance and can be moved up and down by means of a traction rope (3). Thereby the screw connections of adjacent tower segment parts (10a) can be inspected.
Patent AU-2013339057-B2 (AU)
Title: Agent for preventing or improving decline in brain function
Inventor: KUMAGAI KOTA
IPC: A61K31/198
Filed: 2013-10-30
Granted: 2018-08-30
Abstract: An objection of the present invention is to provide an agent for preventing or improving decline in brain function such as decreased perception ability, decreased memory learning ability, decreased thinking ability, decreased concentration, decreased attention, decreased judgment ability, depression, and decreased exercise performance caused thereby. According to the present invention, an agent for protecting brain neuronal cells, comprising citrulline or a salt thereof and glutathione or a salt thereof as active ingredients as well as an agent for preventing or improving decline in brain function, comprising citrulline or a salt thereof and glutathione or a salt thereof as active ingredients is provided.
Patent AU-2013382379-B2 (AU)
Title: Lump crusher for a scraper chain conveyor
Inventor: WLEKLINSKI BERNHARD
IPC: E21F13/06
Filed: 2013-09-12
Granted: 2018-02-22
Abstract: A coarse crusher (18) for use at both face ends of a face conveyor in an underground mine is disclosed. The coarse crusher (18) may comprise a pan module (20), a base-frame module (22) and a support-arm module (24). The pan module (20) has two pan outer longitudinal sides (46, 48). Depending on the face end of the face conveyor, into which face end the coarse crusher (18) is to be integrated, the base-frame module (22) may be fastened releasably via first pan fastening apparatuses (50) to that first or second pan outer longitudinal side (46, 48) which faces away from a working face.
Patent AU-2013398381-B2 (AU)
Title: Generating seismic pulses using piezoelectric devices to map fractures
Inventor: HALL LEE J
IPC: E21B43/14
Filed: 2013-08-20
Granted: 2016-10-13
Abstract: The methods described are for determining distribution, orientation and dimensions of networks of hydraulically-induced fractures within a subterranean formation containing fluids. Detectable signals are generated by particles introduced into the fractures. In an exemplary method acoustic particles are positioned in the formation during fracturing and allowed to generate a signal during or after fracturing activity. The detectable signals generated by the acoustic particles are used to map fracture space.
Patent AU-2014202348-B2 (AU)
Title: Merchandiser with airflow divider
Inventor: NGUYEN KEN
IPC: A47F3/04
Filed: 2014-04-30
Granted: 2015-08-13
Abstract: A refrigerated merchandiser includes a case defining a product display area and having a base, a lower flue, a first air passageway, and a second air passageway. The first air passageway and second air passageway are in fluid communication with the lower flue and with the product display area. A fan plenum has an outlet defining a first plane. A second plane is defined perpendicular to the first plane and passing through the center of a fan aperture. The fan plenum further includes an airflow divider with a first wall member and a second wall member positioned to direct a first portion of the airflow to the first air passageway and a second portion of the airflow to the second air passageway. The space between the first wall member and the second wall member defines an area, the greater portion of which is to one side of the second plane. 5234931_1 (GHMatters) P96648.AU
Patent AU-2014219754-B2 (AU)
Title: Method for producing tricyclic compound, and tricyclic compound capable of being produced by said production method
Inventor: UNO TAKAO
IPC: C07D487/14
Filed: 2014-02-21
Granted: 2016-05-05
Abstract: The purpose of the present invention is to provide a method for producing, with a high yield and high reproducibility, a tricyclic compound containing pyrrolopyridine rings while minimizing byproduct generation, and a novel tricyclic compound capable of being obtained by said method. The present invention provides a method for producing a compound represented by formula (1), or a salt thereof, the method comprising: step [I] of reacting an organoborane reagent with a compound represented by formula (2), or a salt thereof; and step [II] of inducing intramolecular cyclization in the reaction product of step [I] by using a zero-valency palladium catalyst in the presence of an alkali metal hydroxide.
Patent AU-2014231696-B2 (AU)
Title: Production of pulse protein product
Inventor: GREEN BRENT E
IPC: A23J3/14
Filed: 2014-03-10
Granted: 2017-04-27
Abstract: A pulse protein product having a protein content of at least about 50 wt% (N x 6.25) d.b. is recovered in the processing of pulse protein source material to form pulse protein products wherein the pulse protein source is extracted in one embodiment with calcium salt solution. The resulting pulse protein solution is separated from the bulk of the residual pulse protein source and then the pulse protein solution is processed to remove finer residual solids, which are optionally washed and then dried to provide the pulse protein product. In another embodiment, the pulse protein source is extracted with water, the bulk of the residual protein source removed and the resulting pulse protein solution treated with calcium salt to precipitate phytic acid. The precipitated phytic acid and any finer residual solids remaining in solution after the initial separation step are removed from the pulse protein solution then optionally washed and dried to provide the pulse protein product.
Patent AU-2014240533-B2 (AU)
Title: Context-sensitive handling of interruptions
Inventor: LARSON ANTHONY L
IPC: G10L15/22
Filed: 2014-03-11
Granted: 2017-04-20
Abstract: A speech output to be provided to a user of a device is received. Thereafter, it is determined if the device is currently receiving speech input from a user. Upon determining that the device is not currently receiving speech input from the user, the speech output to the user is provided. On the other hand, upon determining that the device is receiving speech input from the user it is determined if provision of the speech output is urgent. When the speech output is urgent, the speech output is provided to the user. When the speech output is not urgent, provision of the speech output to the user is stayed.
Patent AU-2014254768-B2 (AU)
Title: Heterocyclic acetic acid amide compound
Inventor: SHIRAKI RYOTA
IPC: C07D417/12
Filed: 2014-04-18
Granted: 2017-10-05
Abstract: [Problem] To provide a compound of formula (I) that is useful as a dopamine D1 receptor positive allosteric modulator (D1 PAM). [Solution] The inventors studied a compound that has a dopamine D1 receptor positive allosteric modulating action and is useful as an active ingredient for a pharmaceutical composition for preventing and/or treating cognitive dysfunction, negative symptoms of schizophrenia, Parkinson's disease, Alzheimer's disease, Huntington's disease, drug dependence, etc., have verified that a heterocyclic acetic acid amide compound has a dopamine D1 receptor positive allosteric modulating action, and have completed the present invention. This heterocyclic acetic acid amide compound has a dopamine D1 receptor positive allosteric modulating action and may be used as a preventive and/or therapeutic agent for cognitive dysfunction, negative symptoms of schizophrenia, Parkinson's disease, Alzheimer's disease, Huntington's disease, drug dependence, etc.
Patent AU-2014266004-B2 (AU)
Title: Device and system for percussion rock drilling
Inventor: CARLSSON JIMMY
IPC: E21B10/36
Filed: 2014-05-16
Granted: 2018-05-17
Abstract: A drill bit (6) for percussion rock drilling including: - an impact portion (26) with an impact surface (9) for striking against rock in an impact direction (R), - an engagement portion (27) with: i) holder means (10) for holding the drill bit axially in a drill head of a drill string, and ii) rotation engagement means (11) for connecting the drill bit with the drill head for the purpose of rotation of the drill bit (6), - an anvil surface (14) being directed opposite to the impact direction for receiving shock waves from a striker rod (15) of the drill string, and - flushing channel means for transfer of flushing fluid to the impact surface (9). The holder means (10) and the anvil surface (14) are inside a holder recess (17) having an opening that is directed opposite to the impact direction (R). The invention also concerns a drill string component, a system and a method.
Patent AU-2014268536-B2 (AU)
Title: Extendable storage device
Inventor: HALL DAVID
IPC: A47J47/16
Filed: 2014-05-22
Granted: 2018-06-14
Abstract: A storage device comprising an extendable center piece slidingly-attached to one or more supports, the center piece including a slot that runs vertically through the center piece for at least a portion of a length of the center piece and providing a surface to support at least one hook, wherein the hook is disposed in the slot formed in the center piece and the hook extends through the slot and below the bottom surface of the center-piece, each hook providing an interface for hanging and storing an item within a cabinet or other suitable storage space.
Patent AU-2014322925-B2 (AU)
Title: Solution for dissociating vitamin D from vitamin D-binding protein, associated detection method and use
Inventor: MEUNIER VALERIE
IPC: G01N33/82
Filed: 2014-09-16
Granted: 2020-07-02
Abstract: The present invention relates to the use of at least one fluoroalkyl surfactant and of at least one alcohol comprising from 1 to 4 carbon atoms, for dissociating vitamin D, and/or a vitamin D metabolite, from vitamin D-binding protein, and also to a solution comprising at least one fluoroalkyl surfactant and at least one alcohol comprising from 1 to 4 carbon atoms. The subject matter of the invention is also a method for detecting and quantifying,
Patent AU-2014346511-B2 (AU)
Title: Multiuse, enzymatic detergent and methods of stabilizing a use solution
Inventor: CHAN WENDY
IPC: C11D7/12
Filed: 2014-11-10
Granted: 2016-12-22
Abstract: Stabilized use solutions of low phosphorus, alkali metal carbonate detergents employing enzymes for cleaning compositions are disclosed. In particular, the present invention is a composition for, and method of, removing soils, preventing redeposition of protein soils and reducing foam, using stabilized enzyme cleaning compositions, namely use solutions of the same.
Patent AU-2014349246-B2 (AU)
Title: Pharmaceutical composition containing glutarimide derivatives, and application thereof for treating eosinophilic diseases
Inventor: NEBOLSIN VLADIMIR EVGENIEVICH
IPC: C07D211/88
Filed: 2014-11-12
Granted: 2018-10-18
Abstract: ﻿The present invention relates to novel biologically-active glutarimide derivatives of general formula (I) or pharmaceutically acceptable salts thereof, and to the application thereof as means for treating eosinophilic diseases of a predominantly allergic nature, and specifically, bronchial asthma, allergic rhinitis, polypoid rhinosinusitis, eosinophilic colitis, eosinophilic syndrome, allergic conjunctivitis, atopic dermatitis, Churg-Strauss syndrome, anaphylactic shock, Quincke's edema, eosinophilic vasculitis, eosinophilic esophagitis, eosinophilic gastroenteritis and fibrosis, and relates to pharmaceutical compositions containing glutarimide derivatives of general formula (I).
Patent AU-2014415641-B2 (AU)
Title: Electromagnetically coupled band-gap transceivers
Inventor: MA JIN
IPC: E21B47/12
Filed: 2014-12-29
Granted: 2018-03-15
Abstract: A communication system for use in a wellbore can include a first cylindrically shaped band that can be positioned around a first outer housing of a first subsystem of a well tool. The first cylindrically shaped band can be operable to electromagnetically couple with a second cylindrically shaped band. The second cylindrically shaped band can be positioned around a second outer housing of a second subsystem of the well tool. The first cylindrically shaped band can electromagnetically couple with the second cylindrically shaped band via an electromagnetic field or by transmitting a current to the second cylindrically shaped band through a fluid in the wellbore.
Patent AU-2015210453-B2 (AU)
Title: Abuse Resistant Controlled Release Opioid Dosage Form
Inventor: CARUSO FRANK S
IPC: A61K31/485
Filed: 2015-08-07
Granted: 2016-10-13
Abstract: Abuse-Resistant Controlled-Release Opioid Dosage Form Abuse-resistant, controlled release opioid tablets in combination containing an opioid antagonist such as naloxone at a level above that needed to suppress the euphoric effect of the opioid, if the combination were crushed to break the controlled release properties causing the opioid and opioid antagonist to be released as an immediate release product as a single dose. The controlled release nature of the tablet prevents the accumulation of orally effective amounts of opioid antagonist when taken normally. The opioid antagonist is contained in a controlled release matrix and released, over time, with the opioid.
Patent AU-2015233500-B2 (AU)
Title: Stabilization and isolation of extracellular nucleic acids
Inventor: GROLZ DANIEL
IPC: A01N1/02
Filed: 2015-03-18
Granted: 2018-11-01
Abstract: The present invention provides methods, compositions and devices for stabilizing the extracellular nucleic acid population in a cell-containing biological sample using a poly(oxyethylene) polymer or mono-ethylene glycol as stabilizing agent.
Patent AU-2015241034-B2 (AU)
Title: Modified cytosine polynucleotide oligomers and methods
Inventor: GALL ALEXANDER A
IPC: C12Q1/68
Filed: 2015-03-30
Granted: 2020-02-06
Abstract: Disclosed are modified cytosine bases that provide enhanced base-pairing affinity for guanine bases in polynucleotide hybridization complexes. Also disclosed are polynucleotide oligomers, polynucleotide hybridization complexes that comprise such modified cytosine bases. Also disclosed are various methods of use. For example, in some embodiments, modified polynucleotide oligomers disclosed herein can be used as primers and probes for nucleic acid amplification and/or detection.
Patent AU-2015287696-B2 (AU)
Title: Multi-drug delivery system and uses thereof
Inventor: HSIEH PATRICK CH
IPC: C07K2/00
Filed: 2015-07-10
Granted: 2018-06-14
Abstract: Disclosed herein is a multiple drugs delivery system and its uses in treating diseases. The multiple drugs delivery system includes, an anti-PEG antibody for directing the PEGylated therapeutic to the treatment site; and a hydrogel for retaining the anti-PEG antibody and/or the PEGylated therapeutic at the treatment site for at least 3 days. The hydrogel is selected from the group consisting of hyaluronan (HA) or a derivative of HA, collagen, gelatin, fibronectin, fibrinogen, alginate, chitosan, and a synthetic biocompatible polymer. The anti-PEG antibody and the hydrogel are present in the mixture in a ratio from about 1:1 (v/v) to 1:100 (v/v). At least two dosages of the PEGylated therapeutic, which may be the same or different, are administered to the subject, with each dosage being given at about 1 hour to about 1 week apart. Accordingly, a novel method of treating a subject having cancer or ischemia disease is also provided.
Patent AU-2015292050-B2 (AU)
Title: New polycrystalline form of tenofovir prodrug, and preparation method and application therefor
Inventor: CHEN MING
IPC: A61P31/20
Filed: 2015-07-21
Granted: 2019-01-31
Abstract: The present invention relates to a new crystalline form of 9-[(R)-2-[[(S)-[[[1-(isopropoxycarbonyl)-1-methyl]ethyl]amino]phenoxyphosphinyl]methoxy]propyl]adenine fumarate, and a preparation method and application therefor. Specifically, the present invention relates to a new crystalline form of 9-[(R)-2-[[(S)-[[[1-(isopropoxycarbonyl)-1-methyl]ethyl]amino]phenoxyphosphinyl]methoxy]propyl]adenine fumarate represented by formula (I), characterised in that the XRPD pattern of the crystalline form at least includes 2θ ± 0.20
Patent AU-2015352545-B2 (AU)
Title: Pyrrolobenzodiazepine-antibody conjugates
Inventor: VAN BERKEL PATRICIUS HENRIKUS CORNELIS
IPC: A61P35/00
Filed: 2015-11-25
Granted: 2020-10-15
Abstract: The present disclosure relates to the use of antibody-drug conjugates (ADCs) comprising pyrrolobenzodiazepine (PBD) dimers and anti-CD25 antibodies for use in treating disorders characterized by the presence of CD25+ve cells.
Patent AU-2016214075-B2 (AU)
Title: Subsea pipe-in-pipe structures
Inventor: CHERKAOUI SAAD
IPC: F16L59/065
Filed: 2016-01-27
Granted: 2020-02-27
Abstract: A pipe-in-pipe assembly comprises thermally-insulating spacers (24) positioned in an annulus (16) to act radially between inner and outer pipes (12, 18). The spacers comprise at least one circumferentially-extending array of circumferentially-spaced ribs (26) that define longitudinally-extending passageways in gaps (28) between neighbouring ribs of the array. Cables (10) including heating elements extend longitudinally along the annulus outside the inner pipe. The cables extend longitudinally along the passageways. At least one insulation layer (48, 52) disposed radially outboard of the cables comprises insulating elements disposed in the gaps between the ribs and/or an insulating layer extending around the inner pipe, positioned radially outboard of the ribs and bridging the gaps. Bands encircle and retain components of the insulation layer. Insulation may also be disposed on the inner pipe between first and second arrays of ribs, those arrays being spaced longitudinally from each other.
Patent AU-2016237966-B2 (AU)
Title: Resin-Coated Metal Sheet for Container
Inventor: YAMANAKA YOICHIRO
IPC: B32B15/09
Filed: 2016-03-25
Granted: 2018-11-22
Abstract: Provided is a resin coated metal plate that is for a container and that allows excellent content removability and is satisfactory in various properties. When the container is molded, the container has a resin layer (A) having a multi-layered structure on the internal surface side and a resin layer (B) on the external surface side. The resin layer (A) contains, as a main ingredient, a polyester of which 85 mol% or more of the acid component which is a constitutional unit of the polyester is a terephthalic acid unit. In the resin layer (A), a resin layer (a1), which is the uppermost layer that makes contact with the content in the container, contains a specific amount of a wax component and has a specific thickness. The Raman-band intensity ratio (I
Patent AU-2016245932-B2 (AU)
Title: Method of reducing the peak factor of a multichannel emission by intelligent and adaptive clipping/filtering
Inventor: TRAVERSO SYLVAIN
IPC: H04L27/26
Filed: 2016-04-07
Granted: 2020-01-23
Abstract: Method of reducing the peak factor of a signal transmitted in a frequency band comprising several channels, the signal using a plurality of channels in the band, characterized in that it comprises: a step of clipping said signal, a step of subtracting said clipped signal from said signal, so as to obtain a peak signal, a step of filtering said peak signal with the aid of a multichannel filter configured to comply with a spectral template predetermined for each of the channels used by the signal, and a step of subtracting the filtered peak signal from the signal. Associated device emitting a multichannel signal implementing the method of reducing the peak factor.
Patent AU-2016246737-B2 (AU)
Title: Nanoparticle immunoconjugates
Inventor: YOO BARNEY
IPC: A61K51/04
Filed: 2016-04-07
Granted: 2019-11-21
Abstract: Disclosed herein are nanoparticle immunoconjugates useful for therapeutics and/or diagnostics. The immunoconjugates have diameter (e.g., average diameter) no greater than 20 nanometers (e.g., as measured by dynamic light scattering (DLS) in aqueous solution, e.g., saline solution). In certain embodiments, the conjugates are silica-based nanoparticles with single chain antibody fragments attached thereto.